title,journal,year,authors
The role of exosomal PD-L1 in NSCLC immunotherapy.,Immunotherapy,2025,Zhu Li; Shichang Zhang; Yue Wang; Yubo Yan
CD248 induces PD-L1 expression on cancer-associated fibroblasts to promote NSCLC immune escape.,Frontiers in cell and developmental biology,2025,Zeyang Yang; Xuanyin Wang; Xu Zhu; Long Li; Xianling Zeng; Jiaming Ren; Lu Wang; Jiangwei Wu; Qiaoling Zhang; Siyu Wang; Maoqin Lu; Juan Zhai; Xinlei Liu; Jing Xiao; Tao Jin; Ying Zhang; Yun Wang; Jian Zhang; Zhu Zeng; Jieheng Wu
"Administration of a Single Dose of Pembrolizumab, Docetaxel, and Cisplatin Leads to Complete Disappearance of a Locally Advanced Hypopharyngeal Squamous Cell Carcinoma: A Case Report.",Case reports in oncology,2025,Basil Alzahrani; Mohammed Albin Ahmed; Anas Alzahrani; Abbas Alhejji; Ali Al Zahrani
"Targeting of acute myeloid leukemia by five-gene engineered T cells expressing transgenic T-cell receptor specific to WT1, chimeric antigenic receptor specific to GM-CSF receptor, bispecific T-cell engager specific to CD33, and tEGFR suicide gene system.",Immunotherapy advances,2025,Kristýna Šmilauerová; Martin Štach; Martin Mucha; Šárka Vaníková; Jana Rychlá; Pavel Otáhal
Alcohol use reduces the efficacy of anti-PD1 immunotherapy by disrupting anti-tumor immunity.,bioRxiv : the preprint server for biology,2025,Kristen N Gilley; Jason Garness; Ali Khan; Brandon Carpenter; Mitra Shabrang; Wolfgang Beckabir; Chad Pecot; Benjamin Vincent; Leon G Coleman
